{
  "id": 9677164,
  "title": "Kobayashi in ¥500 billion buyout talks after red-yeast case",
  "url": "https://urgent.news/2026/09/25/kobayashi-in-500-billion-buyout-talks-after-red-yeast-case",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T02:24:00.000Z",
  "source": {
    "name": "Japan Times",
    "slug": "japan-times",
    "url": "https://www.japantimes.co.jp/business/2026/09/25/companies/kobayashi-buyout-talks/"
  },
  "original_language": "en",
  "account": "Japanese health products company Kobayashi Pharmaceutical is reportedly in talks for a potential buyout by private equity investors, with the offer valued at over ¥500 billion ($3.2 billion). CVC Capital Partners and Nippon Sangyo Suishin Kiko are among the parties considering a bid to take the company private, according to people with knowledge of the negotiations. Kobayashi's founding family may also participate in the buyout, the sources added. The company received a preliminary, nonbinding joint proposal from the investors earlier this week, but no final decisions have been made yet. As of the market open in Tokyo, Kobayashi shares were not traded and were expected to rise.",
  "summary": "CVC Capital Partners and Nippon Sangyo Suishin Kiko are weighing a bid to take the company private, sources said.",
  "key_points": [
    "Japanese health products company Kobayashi Pharmaceutical in ¥500 billion buyout talks",
    "CVC Capital Partners and Nippon Sangyo Suishin Kiko considering bid to take company private",
    "Kobayashi's founding family may participate in the buyout"
  ],
  "editors_take": "A potential buyout by private equity investors would likely end Kobayashi Pharmaceutical's public status and could bring significant changes to the company's operations and leadership.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}